2) drug release in vitro
体外释放
1.
Programming model methodology for data of drug release in vitro;
体外释放拟合模板编程及应用实例
2.
OBJECTIVE To prepare thymopentin microspheres and investigate the drug release in vitro.
目的制备胸腺五肽微球并对其体外释放进行考察。
3.
Several characteristics of c hitosan nanoparticles such as morphology,particle size,zeta potential,drug entra pment efficiency and drug release in vitro were evaluated.
方法 采用酶水解和超滤膜分离技术 ,得到不同相对分子质量的壳聚糖 ,由凝胶渗透色谱法测定其相对分子质量 ;采用溶剂扩散法制备纳米粒 ,研究纳米粒的空间结构 ,测定其粒径、表面电位 (zeta电位 )、模型药物胰岛素包封率及体外释放。
3) in vitro dissolution
体外释放
1.
Preparation and in vitro dissolution of the solid dispersions of cinnamon oil;
肉桂油固体分散体的制备及体外释放
2.
Preparation and in vitro dissolution of glipizide sustained-release pellet capsules;
格列吡嗪缓释微丸胶囊的制备及其体外释放
3.
Preparation and in vitro dissolution of diclofenac sodium sustained-release tablets;
双氯芬酸钠缓释片的制备和体外释放度研究
4) In vivo release
体内释放
1.
Aim Analyze the in vivo release characteristics of different dosage forms of ibuprofen so as to illustrate the property of the in vivo release of nonparenteral administration.
目的 分析布洛芬不同剂型的体内释放特征 ,揭示血管外给药制剂的体内溶出特征及其意义。
2.
Objective To study the in vivo release characteristic and mechanism of a PLA /PLGA injectable gel delivery system containing doxycycline hydrochloride.
目的考察盐酸多西环素注射用缓释凝胶的体内释放特性及体内外相关性。
5) release in vitro
体外释放
1.
Preparation of diclofenac sodium liposomes by active loading method and its release in vitro;
主动载药法制备双氯芬酸钠脂质体及其体外释放
2.
Influence of gel vehicles on release in vitro and transdermal resorption of integerrimine;
不同基质对全缘千里光碱凝胶剂体外释放和透皮特性的影响
3.
Preparation of irinotecan hydrochloride containing liposomes by ammonium sulfate gradient method and its release in vitro
硫酸铵梯度法制备盐酸伊立替康脂质体及体外释放的研究
6) in vitro release
体外释放
1.
Study on preparation and in vitro release characteristics of Bitongning Patch;
痹痛宁贴剂的制备及体外释放、透皮吸收研究
2.
Preparation and in vitro release of Niacin sustained-release tablets;
烟酸缓释骨架片的制备及体外释放度考察
3.
A study on the preparation and in vitro release models of doxorubicin-nanoparticles;
阿霉素纳米粒的制备与模拟体外释放行为
补充资料：体外释放
分子式：
CAS号：
性质：即将固体药物制剂模拟体内情况在体外所进行的释放试验。体内情况极为复杂，通常只能在温度、搅拌、介质pH值等方面加以模拟。具体实验方法因制剂类型、用途和理化性质等而异。口服缓释或控释制剂一般试验条件为温度37℃，释放介质为人工胃液和人工肠液，有时也可用水。常用的容器有转篮式、桨式、循环式及崩解仪式等数种。在规定时间取样，并及时补充所消耗的溶媒。
CAS号：
性质：即将固体药物制剂模拟体内情况在体外所进行的释放试验。体内情况极为复杂，通常只能在温度、搅拌、介质pH值等方面加以模拟。具体实验方法因制剂类型、用途和理化性质等而异。口服缓释或控释制剂一般试验条件为温度37℃，释放介质为人工胃液和人工肠液，有时也可用水。常用的容器有转篮式、桨式、循环式及崩解仪式等数种。在规定时间取样，并及时补充所消耗的溶媒。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条